Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year By: CNBC.com News July 17, 2023 at 10:15 AM EDT Eli Lilly is racing to market donanemab for Alzheimer's after Eisai and Biogen's drug for the disease, Leqembi, won FDA approval this month. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year By: CNBC.com News July 17, 2023 at 10:15 AM EDT Eli Lilly is racing to market donanemab for Alzheimer's after Eisai and Biogen's drug for the disease, Leqembi, won FDA approval this month. Read More >>